Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Lymphoma, Large B-Cell, Diffuse, Triple Negative Breast Neoplasms

NCT04047862 2025-08-22

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

Phase 1 Completed

446 enrolled 49 charts

Other solid neoplasm

Locally Advanced and Metastatic Solid Tumors

NCT06953323 2025-08-13

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

Phase 1/2 Recruiting

86 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT03537690 2025-08-12

FID-007 in Treating Participants With Advanced Solid Tumors

Phase 1 Active not recruiting

50 enrolled

Other solid neoplasm

Advanced Malignant Solid Neoplasm

NCT05275777 2025-07-25

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer

Phase 1/2 Active not recruiting

66 enrolled

BreastOther solid neoplasm

HER2-negative Breast Cancer

NCT06208410 2025-07-25

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

Phase 1/2 Recruiting

306 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05978492 2025-04-24

A Study of TXN10128 in Subjects With Solid Tumors

Phase 1 Recruiting

96 enrolled

Other solid neoplasm

Locally Advanced (Unresectable) or Metastatic Solid Tumors

Clinical Trials

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors

A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors

A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors

MICA

A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

A Study of WJ05129 in Advanced Malignant Solid Tumors

A Study of NX-1607 in Adults With Advanced Malignancies

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

FID-007 in Treating Participants With Advanced Solid Tumors

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

A Study of TXN10128 in Subjects With Solid Tumors